2010 Scrip 100 - EMA showing it has nothing to hide
This article was originally published in Scrip
Executive Summary
European Medicines Agency executive director Thomas Lönngren talks to Maureen Kenny about the complicated matter of transparency, funding headaches, why the pharmaceutical industry should be allowed to provide information about their drugs to patients, dealing with conflicts of interests among scientific experts and lots more besides.